Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with the Welsh Government with regard to the international travel implications for British citizens who have received Covishield branded Astrazeneca covid-19 vaccinations.

We continue to have regular discussions with the devolved administrations on a range of issues.

AstraZeneca doses branded as ‘Covishield’ are not approved by the Medicines and Healthcare products Regulatory Agency and have not been administered in the United Kingdom. All doses of AstraZeneca COVID-19 vaccines administered in the UK are the same product, which appear on the NHS COVID Pass as Vaxzevria.

The Government continues to engage with other countries regarding certification to ensure that global travel is supported by a common approach.